This statistic depicts the percentage of worldwide prescription drug revenue at risk due to patent expirations from 2010 to 2024. In 2012, around seven percent of the market was at risk due to patent expirations on pharmaceutical drug revenues.
Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
Percentage of global prescription drug revenue at risk
Total Sales at Risk’ represents the worldwide product sales in the year prior to patent expiry but allocated to the year of expiry. E.g. Plavix had sales of $7.1bn in 2011, this is shown as ‘At Risk’ in 2012.
* Projected.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Evaluate. (June 4, 2019). Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024 [Graph]. In Statista. Retrieved February 26, 2020, from https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. "Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024." Chart. June 4, 2019. Statista. Accessed February 26, 2020. https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. (2019). Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024. Statista. Statista Inc.. Accessed: February 26, 2020. https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. "Percentage of Global Prescription Drug Revenue at Risk from Patent Expiration from 2010 to 2024." Statista, Statista Inc., 4 Jun 2019, https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate, Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024 Statista, https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/ (last visited February 26, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
